Anti-PIAS1 + PIAS2 抗体 [EPR2581Y] (ab77231)
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit monoclonal [EPR2581Y] to PIAS1 + PIAS2
- Suitable for: ICC/IF, WB, IHC-P
- Reacts with: Human, Recombinant fragment
Related conjugates and formulations
製品の概要
-
製品名
Anti-PIAS1 + PIAS2 antibody [EPR2581Y]
PIAS1+PIAS2 一次抗体 製品一覧 -
製品の詳細
Rabbit monoclonal [EPR2581Y] to PIAS1 + PIAS2 -
由来種
Rabbit -
アプリケーション
適用あり: ICC/IF, WB, IHC-Pmore details -
種交差性
交差種: Human, Recombinant fragment
交差が予測される動物種: Mouse, Rat -
免疫原
Synthetic peptide within Human PIAS1 aa 600 to the C-terminus (C terminal). The exact sequence is proprietary.
Database link: O75925 -
ポジティブ・コントロール
- Daudi, 293, Jurkat, SW40 and HepG2 cell lysates; human tonsil tissue.
-
特記事項
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles. -
バッファー
pH: 7.20
Preservative: 0.01% Sodium azide
Constituents: 9% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA, 50% Tissue culture supernatant -
Concentration information loading...
-
精製度
Protein A purified -
ポリ/モノ
モノクローナル -
クローン名
EPR2581Y -
アイソタイプ
IgG -
研究分野
関連製品
-
Isotype control
-
Positive Controls
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab77231の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
アプリケーション | Abreviews | 特記事項 |
---|---|---|
ICC/IF | (1) |
1/100 - 1/500.
|
WB | (1) |
1/1000 - 1/10000. Predicted molecular weight: 72 kDa.
|
IHC-P |
1/100 - 1/250. Perform heat mediated antigen retrieval via the pressure cooker method before commencing with IHC staining protocol.
|
特記事項 |
---|
ICC/IF
1/100 - 1/500. |
WB
1/1000 - 1/10000. Predicted molecular weight: 72 kDa. |
IHC-P
1/100 - 1/250. Perform heat mediated antigen retrieval via the pressure cooker method before commencing with IHC staining protocol. |
ターゲット情報
-
細胞内局在
PIAS1: Nucleus speckle. Interaction with CSRP2 may induce a partial redistribution along the cytoskeleton. PIAS2: Nucleus speckle. Nucleus, PML body. Nucleus. Colocalizes at least partially with promyelocytic leukemia nuclear bodies (PML NBs) (PubMed:22406621). Colocalizes with SUMO1 in nuclear granules (By similarity). -
参照データベース
- Entrez Gene: 8554 Human
- Entrez Gene: 9063 Human
- Entrez Gene: 17344 Mouse
- Entrez Gene: 56469 Mouse
- Entrez Gene: 300772 Rat
- Entrez Gene: 83422 Rat
- Omim: 603566 Human
- Omim: 603567 Human
see all
画像
-
All lanes : Anti-PIAS1 + PIAS2 antibody [EPR2581Y] (ab77231) at 1/50000 dilution
Lane 1 : Human PIAS1 full-length recombinant protein with GST-Tag
Lane 2 : Human PIAS2-beta recombinant protein fragment with GST-His-Tag
Lane 3 : Human PIAS3 recombinant protein fragment with SUMO-His-Tag
Lysates/proteins at 0.015 µg per lane.
Secondary
All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/20000 dilution
Predicted band size: 72 kDa
Observed band size: 98, 42 kDa why is the actual band size different from the predicted?Blocking and Diluting buffer and concentration: 5% NFDM /TBST
Exposure time: Lane1:10 seconds, Lane2: 5 seconds, Lane3: 3 minutes.
Human PIAS1 full-length recombinant protein (Cat#: ab152888)
-
All lanes : Anti-PIAS1 + PIAS2 antibody [EPR2581Y] (ab77231) at 1/50000 dilution
Lane 1 : Daudi cell lysate
Lane 2 : 293 cell lysate
Lane 3 : Jurkat cell lysate
Lane 4 : SW40 cell lysate
Lane 5 : HepG2 cell lysate
Lysates/proteins at 10 µg per lane.
Secondary
All lanes : HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 72 kDa
Observed band size: 78 kDa why is the actual band size different from the predicted? -
Immunocytochemistry/Immunofluorescence analysis of HeLa (human cervix adenocarcinoma) cells labelling PIAS1 + PIAS2 with purified ab77231 at 1/500. Cells were fixed with 4% Paraformaldehyde and permeabilized with 0.1% Triton X-100. ab150077, Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/1000) was used as the secondary antibody. Nuclei were counterstained with DAPI (blue).
Secondary Only Control: PBS was used instead of the primary antibody as the negative control.
-
ab77231, at a 1/100 dilution, staining PIAS1 + PIAS2 in paraffin embedded human tonsil tissue by Immunohistochemistry.
Perform heat mediated antigen retrieval via the pressure cooker method before commencing with IHC staining protocol.
プロトコール
データシートおよび資料
-
SDS download
-
Datasheet download
参考文献 (18)
ab77231 は 18 報の論文で使用されています。
- Paakinaho V et al. SUMOylation regulates the protein network and chromatin accessibility at glucocorticoid receptor-binding sites. Nucleic Acids Res 49:1951-1971 (2021). PubMed: 33524141
- Li Y et al. PAK5 promotes RNA helicase DDX5 sumoylation and miRNA-10b processing in a kinase-dependent manner in breast cancer. Cell Rep 37:110127 (2021). PubMed: 34936874
- Guérillon C et al. Multisite SUMOylation restrains DNA polymerase ? interactions with DNA damage sites. J Biol Chem 295:8350-8362 (2020). PubMed: 32350109
- Zhang K et al. Protein inhibitor of activated STAT1 (PIAS1) inhibits IRF8 activation of Epstein-Barr virus lytic gene expression. Virology 540:75-87 (2020). PubMed: 31743858
- Josa-Prado F et al. Developmental profiles of SUMOylation pathway proteins in rat cerebrum and cerebellum. PLoS One 14:e0212857 (2019). PubMed: 30794696